Muda M, Boschert U, Dickinson R, Martinou J C, Martinou I, Camps M, Schlegel W, Arkinstall S
Glaxo Institute for Molecular Biology, CH-1228 Plan-les-Ouates, Geneva, Switzerland.
J Biol Chem. 1996 Feb 23;271(8):4319-26. doi: 10.1074/jbc.271.8.4319.
MKP-1 (also known as CL100, 3CH134, Erp, and hVH-1) exemplifies a class of dual-specificity phosphatase able to reverse the activation of mitogen-activated protein (MAP) kinase family members by dephosphorylating critical tyrosine and threonine residues. We now report the cloning of MKP-3, a novel protein phosphatase that also suppresses MAP kinase activation state. The deduced amino acid sequence of MKP-3 is 36% identical to MKP-1 and contains the characteristic extended active-site sequence motif VXVHCXXGXSRSXTXXXAYLM (where X is any amino acid) as well as two N-terminal CH2 domains displaying homology to the cell cycle regulator Cdc25 phosphatase. When expressed in COS-7 cells, MKP-3 blocks both the phosphorylation and enzymatic activation of ERK2 by mitogens. Northern analysis reveals a single mRNA species of 2.7 kilobases with an expression pattern distinct from other dual-specificity phosphatases. MKP-3 is expressed in lung, heart, brain, and kidney, but not significantly in skeletal muscle or testis. In situ hybridization studies of MKP-3 in brain reveal enrichment within the CA1, CA3, and CA4 layers of the hippocampus. Metrazole-stimulated seizure activity triggers rapid (<1 h) but transient up-regulation of MKP-3 mRNA in the cortex, piriform cortex, and some amygdala nuclei. Metrazole stimulated similar regional up-regulation of MKP-1, although this was additionally induced within the thalamus. MKP-3 mRNA also undergoes powerful induction in PC12 cells after 3 h of nerve growth factor treatment. This response appears specific insofar as epidermal growth factor and dibutyryl cyclic AMP fail to induce significant MKP-3 expression. Subcellular localization of epitope-tagged MKP-3 in sympathetic neurons reveals expression in the cytosol with exclusion from the nucleus. Together, these observations indicate that MKP-3 is a novel dual-specificity phosphatase that displays a distinct tissue distribution, subcellular localization, and regulated expression, suggesting a unique function in controlling MAP kinase family members. Identification of a second partial cDNA clone (MKP-X) encoding the C-terminal 280 amino acids of an additional phosphatase that is 76% identical to MKP-3 suggests the existence of a distinct structurally homologous subfamily of MAP kinase phosphatases.
MKP-1(也称为CL100、3CH134、Erp和hVH-1)是一类双特异性磷酸酶的代表,它能够通过使关键的酪氨酸和苏氨酸残基去磷酸化来逆转丝裂原活化蛋白(MAP)激酶家族成员的激活状态。我们现在报告了MKP-3的克隆,它是一种新型的蛋白磷酸酶,也能抑制MAP激酶的激活状态。MKP-3推导的氨基酸序列与MKP-1有36%的同源性,并且包含特征性的延长活性位点序列基序VXVHCXXGXSRSXTXXXAYLM(其中X为任意氨基酸),以及两个与细胞周期调节因子Cdc25磷酸酶具有同源性的N端CH2结构域。当在COS-7细胞中表达时,MKP-3能阻断有丝分裂原对ERK2的磷酸化和酶促激活。Northern分析显示有一个2.7千碱基的单一mRNA种类,其表达模式与其他双特异性磷酸酶不同。MKP-3在肺、心脏、脑和肾中表达,但在骨骼肌或睾丸中表达不明显。对脑中MKP-3的原位杂交研究显示,在海马体的CA1、CA3和CA4层中有富集。戊四氮刺激的癫痫活动能触发皮质、梨状皮质和一些杏仁核中MKP-3 mRNA快速(<1小时)但短暂的上调。戊四氮刺激也能使MKP-有所诱导,尽管在丘脑中也有额外的诱导。在神经生长因子处理3小时后,PC12细胞中MKP-3 mRNA也会受到强烈诱导。这种反应似乎具有特异性,因为表皮生长因子和二丁酰环磷腺苷不能诱导显著的MKP-3表达。在交感神经元中对表位标记的MKP-3进行亚细胞定位显示,它在细胞质中表达,而不在细胞核中。总之,这些观察结果表明MKP-3是一种新型的双特异性磷酸酶,具有独特的组织分布、亚细胞定位和调控表达,提示其在控制MAP激酶家族成员方面具有独特功能。另一个部分cDNA克隆(MKP-X)的鉴定,它编码另一种磷酸酶的C端280个氨基酸,与MKP-3有76%的同源性,这表明存在一个独特的结构同源MAP激酶磷酸酶亚家族。